Tarsus Pharmaceuticals CEO Bobak Azamian's 2022 pay falls 43% to $3.9M
Tarsus Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: April 26, 2023
Tarsus Pharmaceuticals reported fiscal year 2022 executive compensation information on April 26, 2023.
In 2022, three executives at Tarsus Pharmaceuticals received on average a compensation package of $3.2M, a 25% decrease compared to previous year.
Average pay of disclosed executives at Tarsus Pharmaceuticals
Bobak Azamian, Chief Executive Officer, received $3.9M in total, which decreased by 43% compared to 2021. 53% of Azamian's compensation, or $2.1M, was in option awards. Azamian also received $325K in non-equity incentive plan, $590K in salary, $877K in stock awards, as well as $48K in other compensation.
Jose Trevejo, Chief Medical Officer, received a compensation package of $3M. 54% of the compensation package, or $1.6M, was in option awards.
Bryan Wahl, General Counsel, earned $2.5M in 2022, a 4% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2023.